Erbitux and Radial nerve dysfunction - a phase IV clinical study of FDA data

Summary:

Radial nerve dysfunction is reported only by a few people who take Erbitux.

The phase IV clinical study analyzes which people take Erbitux and have Radial nerve dysfunction. It is created by eHealthMe based on reports of 17,969 people who have side effects while taking Erbitux from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 13, 2023

17,969 people reported to have side effects when taking Erbitux.
Among them, 1 person (0.01%) has Radial nerve dysfunction.

What is Erbitux?

Erbitux has active ingredients of cetuximab. It is often used in cancer. eHealthMe is studying from 18,018 Erbitux users for its effectiveness, alternative drugs and more.

What is Radial nerve dysfunction?

Radial nerve dysfunction (damage to arm nerve) is found to be associated with 548 drugs and 394 conditions by eHealthMe.

Number of Erbitux and Radial nerve dysfunction reports submitted per year:

Could Erbitux cause Radial nerve dysfunction?

Gender of people who have Radial nerve dysfunction when taking Erbitux *:

female: 100 %
male: 0.0 %

Age of people who have Radial nerve dysfunction when taking Erbitux *:

Common side effects people have besides Radial nerve dysfunction *:

Weight Decreased: 1 person, 100.00%
Swelling Face: 1 person, 100.00%
Rashes (redness): 1 person, 100.00%
Pharyngeal Oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal): 1 person, 100.00%
Oropharyngeal Pain: 1 person, 100.00%
Nasal Inflammation (inflammation of nose): 1 person, 100.00%
Bone Pain: 1 person, 100.00%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 1 person, 100.00%

Common conditions people have *:

Oral Cancer (mouth cancer): 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Erbitux and have Radial nerve dysfunction?

Check whether Radial nerve dysfunction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Gupta D, Shukla P, Bisht SS, Bhatt ML, Pant MC, Srivastava K, "Deep vein and artery thrombosis associated with cetuximab-based chemoradiotherapy", Indian journal of pharmacology, 2011 Jan .

Related studies

How severe was Radial nerve dysfunction and when was it recovered:

Radial nerve dysfunction in Erbitux

Expand to all the drugs that have ingredients of cetuximab:

Radial nerve dysfunction and drugs with ingredients of cetuximab

Alternative drugs to, pros and cons of Erbitux:

Erbitux (18,018 reports)

Common Erbitux side effects:

Rashes (redness): 2,036 reports
Diarrhea: 1,052 reports
Breathing difficulty: 884 reports
Hypotension (abnormally low blood pressure): 803 reports
Nausea and vomiting: 733 reports
Dehydration (dryness resulting from the removal of water): 670 reports
Death: 659 reports
Fever: 643 reports

Browse all side effects of Erbitux:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Radial nerve dysfunction treatments and more:

Radial nerve dysfunction (502 reports)

COVID vaccines that are related to Radial nerve dysfunction:

All the drugs that are associated with Radial nerve dysfunction:

Radial nerve dysfunction (548 drugs)

All the conditions that are associated with Radial nerve dysfunction:

Radial nerve dysfunction (394 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cetuximab (the active ingredients of Erbitux) and Erbitux (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.